Kidney cancer vaccine made from your own immune cells
Treatments studied
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This Phase 2 study tests a personalized kidney cancer vaccine made from your own immune cells. It aims to help your immune system recognize and attack clear cell kidney cancer after surgery, potentially lowering the chance of the cancer coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have clear cell kidney cancer that has not spread outside the kidney and can be fully removed with surgery
- You are 18 or older and strong enough to do daily activities (performance status 0 or 1)
- If you will receive the vaccine, you must be HLA-A2 positive (a blood test for matching immune system markers)
- You must be able to understand the study and sign consent
- Your blood counts and organ function must meet specific lab thresholds close to the start of treatment
- You must not be pregnant or breastfeeding, and you must use effective birth control during the study and for 4 months after your last dose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized vaccine made from your tumor's unique mutations, given with the immunotherapy drug pembrolizumab, for people with advanced kidney cancer that has stopped responding to standard treatment.
This trial tests a combination of a kidney-cancer vaccine and an immune cell treatment to help stop or shrink renal cell carcinoma. It is designed for people who have measurable tumors and are well enough to participate.
This study looks at genetic (RNA) testing of kidney cancer tissue to help choose the best drug treatment. It may help guide therapy for people with advanced or metastatic clear cell kidney cancer who are starting treatment for the first time.
This trial tests a personalized vaccine made from your own cells to help your immune system attack tumor-specific targets. It may be an option if standard treatments have stopped working or caused side effects you can't tolerate.
This trial tests a personalized therapy made from your own immune cells. Doctors will take a sample of your tumor, find cells that recognize your cancer, grow them in the lab, and give them back to you to fight your advanced solid tumor that has not responded to other treatments.
This early-phase trial tests a whole-cell cancer vaccine for people with certain metastatic cancers. It aims to help your immune system recognize and fight the cancer, especially when prior chemotherapy hasn’t worked.
Hear when a new Carcinoma, Renal Cell trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.